Term ends Dec 9, 2037 · Low confidence
20-year base term ends Dec 9, 2037
Dec 9, 2017
Dec 9, 2037
Mar 23, 2021
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 1 of 3 maintenance fees is paid so far. Confidence: Low. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Dec 9, 2017, when application PCT/US2017/065482, the earliest non-provisional in its chain, was filed (this one was filed Feb 18, 2020); a parent in its chain could not be resolved (the next row) | Dec 9, 2037 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,584,112, US 10,584,113, US 10,759,778, US 10,858,341) | resolves to Dec 9, 2037, no earlier than this term, so no change | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Dec 9, 2037 | Low confidence |
This family
| US 10,584,113 | In force no later than Dec 2037 | no later than Dec 2037 |
| US 10,584,112 | In force no later than Dec 2037 | no later than Dec 2037 |
| US 10,759,778 | In force Dec 2037 | Dec 2037 |
| US 11,021,459 | In force Dec 2037 | Dec 2037 |
| US 11,021,460 | In force Dec 2037 | Dec 2037 |
| US 10,954,212 | In force Dec 2037 | Dec 2037 |
| US 10,954,213 | this patent Dec 2037 | Dec 2037 |
| US 10,858,341 | In force Dec 2037 | Dec 2037 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jan 14, 2021 Reel 54919, frame 909 | Mickle, Travis; Guenther, Sven; Chi, Guochen | Kempharm, Inc. | Assignment of Assignor's Interest |
| Feb 26, 2024 Reel 66679, frame 668 | Kempharm, Inc. | Zevra Therapeutics, Inc. | Change of Name |
| Apr 8, 2024 Reel 67040, frame 637 | Zevra Therapeutics, Inc. | Alter Domus (US) LLC | Security Interest |
| Mar 13, 2026 Reel 75080, frame 907 | Alter Domus (US) LLC | Zevra Therapeutics, Inc. | Release of Security Interest |
| Mar 25, 2026 Reel 74186, frame 531 | Zevra Therapeutics, Inc. | Commave Therapeutics S.A. | Assignment of Assignor's Interest |
| Mar 26, 2026 Reel 74195, frame 8 | Zevra Therapeutics, Inc. | Commave Therapeutics S.A. | Assignment of Assignor's Interest |
| Sep 11, 2026 Reel 75980, frame 787 | Commave Therapeutics S.A. | Truist Bank, As Administrative Agent | Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 10,584,112, US 10,584,113, US 10,759,778, US 10,858,341, ends no earlier than this term, so it caps nothing.